We're well aware of that, but most of the special access products are for products that were never registered in Canada. It's a workaround to get them into the country.
On February 7th, 2019. See this statement in context.
On February 7th, 2019. See this statement in context.
February 7th, 2019 / 9:30 a.m.
Chief Executive Officer, Pharmascience
We're well aware of that, but most of the special access products are for products that were never registered in Canada. It's a workaround to get them into the country.
See context to find out what was said next.